Ginseng

American Ginseng is Found to Improve Cancer-Related Fatigue

The Mayo Clinic conducted a multisite, double-blind trial on the effects of American Ginseng on cancer-related fatigue. 364 patients at 40 different institutions, were given 2000Mg of American Ginseng daily or a Placebo for 8 weeks.  The results were posted at PubMed.gov, below is a copy of the publication.

 

J Natl Cancer Inst. 2013 Aug 21;105(16):1230-8. doi: 10.1093/jnci/djt181. Epub 2013 Jul 13.

Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Source

Alliance Statistics and Data Center, Mayo Clinic Rochester, Rochester, MN 55905, USA. barton.debra@mayo.edu

Abstract

BACKGROUND:

Safe, effective interventions to improve cancer-related fatigue (CRF) are needed because it remains a prevalent, distressing, and activity-limiting symptom. Based on pilot data, a phase III trial was developed to evaluate the efficacy of American ginseng on CRF.

METHODS:

A multisite, double-blind trial randomized fatigued cancer survivors to 2000mg of American ginseng vs a placebo for 8 weeks. The primary endpoint was the general subscale of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) at 4 weeks. Changes from baseline at 4 and 8 weeks were evaluated between arms by a two-sided, two-sample t test. Toxicities were evaluated by self-report and the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE) provider grading.

RESULTS:

Three hundred sixty-four participants were enrolled from 40 institutions. Changes from baseline in the general subscale of the MFSI-SF were 14.4 (standard deviation [SD] = 27.1) in the ginseng arm vs 8.2 (SD = 24.8) in the placebo arm at 4 weeks (P = .07). A statistically significant difference was seen at 8 weeks with a change score of 20 (SD = 27) for the ginseng group and 10.3 (SD = 26.1) for the placebo group (P = .003). Greater benefit was reported in patients receiving active cancer treatment vs those who had completed treatment. Toxicities per self-report and CTCAE grading did not differ statistically significantly between arms.

CONCLUSIONS:

Data support the benefit of American ginseng, 2000mg daily, on CRF over an 8-week period. There were no discernible toxicities associated with the treatment. Studies to increase knowledge to guide the role of ginseng to improve CRF are needed.

PMID: 23853057 [PubMed - indexed for MEDLINE]

I have been taking Ginseng for years now and I notice a difference in my energy levels. If you have also been taking Ginseng and have had similar or other results please comment below.

Comment on Facebook

Leave A Response

* Denotes Required Field